Analyst consensus rating
Clover Health Investments Analyst Rating: Buy
Direct answer
Clover Health Investments's consensus rating is Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.60.
Forecast evidence checked November 14, 2026.
Get free Clover Health Investments email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.96
- Average price target
- $5.60
- High price target
- $6.00
- Low price target
- $5.00
- Low target gap
- +0.8%
- Target upside
- +12.9%
- High target gap
- +21%
- Target range width
- 20.2%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Clover Health Investments?
Clover Health Investments has a verified Buy consensus. The same dataset has an average price target of $5.60.
How far are Clover Health Investments's low and high targets from the recorded price?
The low target implies +0.8%, while the high target implies +21%.
How many analysts are included in Clover Health Investments's consensus?
The verified consensus includes 5 analysts.
How is Clover Health Investments's target upside or downside calculated?
The average target of $5.60 is divided by the recorded price of $4.96, then one is subtracted to produce +12.9%. This does not guarantee a future return.
When was Clover Health Investments's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.